US Stock MarketDetailed Quotes

BDSX Biodesix

Watchlist
  • 1.315
  • +0.035+2.73%
Trading Nov 25 12:13 ET
191.29MMarket Cap-3554P/E (TTM)

About Biodesix Company

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Company Profile

SymbolBDSX
Company NameBiodesix
Listing DateOct 28, 2020
Issue Price18.00
Founded2005
CEOMr. Scott Hutton
MarketNASDAQ
Employees217
Fiscal Year Ends12-31
Address919 West Dillon Road
CityLouisville
ProvinceColorado
CountryUnited States of America
Zip Code80027
Phone1-303-417-0500

Company Executives

  • Name
  • Position
  • Salary
  • Scott Hutton
  • President, Chief Executive Officer and Director
  • 2.29M
  • Robin Harper Cowie
  • Chief Financial Officer, Secretary and Treasurer
  • 844.37K
  • Kieran O’Kane
  • Chief Commercial Officer
  • 672.62K
  • Christopher Vazquez
  • Vice President, Chief Accounting Officer and Controller
  • --
  • John Patience
  • Chairman of the Board
  • 187.58K
  • Jean M. Franchi
  • Independent Director
  • 206.10K
  • Dr. Matthew W. Strobeck, PhD
  • Independent Director
  • 196.84K
  • Lawrence T. Kennedy
  • Independent Director
  • 465.10K
  • Dr. Charles Watts, M.D.
  • Independent Director
  • 187.58K
  • Jack W. Schuler
  • Independent Director
  • 187.58K
  • Hany Massarany
  • Independent Director
  • 201.47K
  • Dr. Jon Faiz Kayyem
  • Independent Director
  • 187.58K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data